• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

竞争性置换对氟哌啶醇在正常血脂和高血脂血浆中血浆分布的影响。

The effects of competitive displacement on haloperidol's plasma distribution in normolipidemic and hyperlipidemic plasma.

作者信息

Procyshyn Ric M, Ho Tiffany, Wasan Kishor M

机构信息

Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Drug Dev Ind Pharm. 2005 Oct;31(9):901-5. doi: 10.1080/03639040500272058.

DOI:10.1080/03639040500272058
PMID:16306002
Abstract

PURPOSE

To assess whether dyslipidemia affects haloperidol's overall plasma distribution when it is in the presence of another highly protein bound drug that competes for plasma protein binding sites.

METHODS

We performed in vitro studies in which warfarin sodium was pre-incubated in normolipidemic and hyperlipidemic plasma samples in varying concentrations. Following the pre-incubation with warfarin, [3H]-haloperidol mixed with unlabeled haloperidol was added to the plasma samples. The plasma was separated into its lipoprotein and lipoprotein deficient fractions by density gradient ultracentrifugation and haloperidol distribution was determined.

RESULTS

Our results indicate that when normolipidemic plasma was pre-incubated with various concentrations of warfarin no significant redistribution of haloperidol was noted among the various plasma lipoprotein fractions. However, in the case of the hyperlipidemic plasma, pre-incubating with warfarin did result in a significant redistribution of haloperidol from the lipoprotein-deficient fraction to the very-low-density and low-density fractions of lipoproteins.

CONCLUSION

Understanding how plasma lipoproteins influence competitive displacement interactions would be valuable in helping to explain and perhaps predict pharmacokinetic parameters that may affect clinical outcome. The clinical significance of competitive displacement of drugs in patients with dyslipidemia requires further study.

摘要

目的

评估在存在另一种竞争血浆蛋白结合位点的高蛋白结合药物时,血脂异常是否会影响氟哌啶醇的整体血浆分布。

方法

我们进行了体外研究,将华法林钠在不同浓度的正常血脂和高脂血症血浆样本中进行预孵育。在与华法林预孵育后,将[3H] - 氟哌啶醇与未标记的氟哌啶醇混合加入血浆样本中。通过密度梯度超速离心将血浆分离为脂蛋白和脂蛋白缺乏部分,并测定氟哌啶醇的分布。

结果

我们的结果表明,当正常血脂血浆与不同浓度的华法林预孵育时,在各种血浆脂蛋白部分中未观察到氟哌啶醇的显著重新分布。然而,在高脂血症血浆的情况下,与华法林预孵育确实导致氟哌啶醇从脂蛋白缺乏部分显著重新分布到极低密度和低密度脂蛋白部分。

结论

了解血浆脂蛋白如何影响竞争性置换相互作用,对于帮助解释甚至预测可能影响临床结果的药代动力学参数将是有价值的。血脂异常患者中药物竞争性置换的临床意义需要进一步研究。

相似文献

1
The effects of competitive displacement on haloperidol's plasma distribution in normolipidemic and hyperlipidemic plasma.竞争性置换对氟哌啶醇在正常血脂和高血脂血浆中血浆分布的影响。
Drug Dev Ind Pharm. 2005 Oct;31(9):901-5. doi: 10.1080/03639040500272058.
2
Competitive displacement of clozapine from plasma proteins in normolipidemic and hyperlipidemic plasma samples: clinical implications.氯氮平在正常血脂和高血脂血浆样本中从血浆蛋白上的竞争性置换:临床意义
Drug Dev Ind Pharm. 2005 May;31(4-5):331-7. doi: 10.1081/ddc-54305.
3
The influence of dyslipidemia on the plasma protein and lipoprotein distribution of haloperidol.
Eur Neuropsychopharmacol. 2003 Jan;13(1):33-7. doi: 10.1016/s0924-977x(02)00078-0.
4
Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine.脂蛋白脂质浓度和组成的差异会改变环孢素的血浆分布。
Pharm Res. 1997 Nov;14(11):1613-20. doi: 10.1023/a:1012190620854.
5
Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.卤泛群脂蛋白分布的差异受脂蛋白非极性脂质、蛋白质浓度及脂质转运蛋白I活性调控:正常血脂及血脂异常人血浆的体外研究
J Pharm Sci. 1999 Feb;88(2):185-90. doi: 10.1021/js980353k.
6
Cholesteryl ester transfer activity. Localization and role in distribution of cholesteryl ester among lipoproteins in man.胆固醇酯转移活性。在人体内脂蛋白间胆固醇酯分布中的定位及作用。
Atherosclerosis. 1984 Mar;50(3):261-71. doi: 10.1016/0021-9150(84)90074-1.
7
The in vitro plasma distribution of a novel cholesteryl ester transfer protein inhibitor, torcetrapib, is influenced by differences in plasma lipid concentrations.新型胆固醇酯转移蛋白抑制剂托彻普(torcetrapib)的体外血浆分布受血浆脂质浓度差异的影响。
Pharm Res. 2006 May;23(5):1025-30. doi: 10.1007/s11095-006-9908-2. Epub 2006 May 4.
8
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.载脂蛋白C-III的脂蛋白分布及其与富含甘油三酯的残余脂蛋白在血浆中存在的关系。
Metabolism. 2001 Jan;50(1):112-9. doi: 10.1053/meta.2001.19452.
9
Plasma protein and lipoprotein distribution of clozapine.
Am J Psychiatry. 2001 Jun;158(6):949-51. doi: 10.1176/appi.ajp.158.6.949.
10
Blood distribution of levocetirizine, a new non-sedating histamine H1-receptor antagonist, in humans.新型非镇静性组胺H1受体拮抗剂左西替利嗪在人体中的血液分布情况。
Fundam Clin Pharmacol. 2002 Dec;16(6):471-8. doi: 10.1046/j.1472-8206.2002.00111.x.